Signaling repurposable drug combinations against COVID-19 by developing the heterogeneous deep herb-graph method

Author:

Yang Fan1,Zhang Shuaijie1,Pan Wei1,Yao Ruiyuan2,Zhang Weiguo2,Zhang Yanchun3,Wang Guoyin4,Zhang Qianghua4,Cheng Yunlong4,Dong Jihua5,Ruan Chunyang6,Cui Lizhen7,Wu Hao7,Xue Fuzhong1

Affiliation:

1. The Department of Epidemiology and Biostatistics , School of Public Health, Cheeloo College of Medicine, Shandong University, China

2. Shandong University of Traditional Chinese Medicine , Jinan, China

3. Institute for Sustainable Industries & Liveable Cities , Victoria University, Australia; The Department of New Networks, Peng Cheng Laboratory, Shenzhen, China

4. Chongqing Key Laboratory of Computational Intelligence , Chongqing University of Posts and Telecommunications, Chongqing, China

5. The School of Foreign Languages and Literature , Shandong University

6. Department of Data Science and Big Data Technology , Shanghai International Studies University, Shanghai, 200083, China

7. School of Software , Shandong University, Jinan, China

Abstract

Abstract Background Coronavirus disease 2019 (COVID-19) has spurred a boom in uncovering repurposable existing drugs. Drug repurposing is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. Motivation Current works of drug repurposing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are mostly limited to only focusing on chemical medicines, analysis of single drug targeting single SARS-CoV-2 protein, one-size-fits-all strategy using the same treatment (same drug) for different infected stages of SARS-CoV-2. To dilute these issues, we initially set the research focusing on herbal medicines. We then proposed a heterogeneous graph embedding method to signaled candidate repurposing herbs for each SARS-CoV-2 protein, and employed the variational graph convolutional network approach to recommend the precision herb combinations as the potential candidate treatments against the specific infected stage. Method We initially employed the virtual screening method to construct the ‘Herb-Compound’ and ‘Compound-Protein’ docking graph based on 480 herbal medicines, 12,735 associated chemical compounds and 24 SARS-CoV-2 proteins. Sequentially, the ‘Herb-Compound-Protein’ heterogeneous network was constructed by means of the metapath-based embedding approach. We then proposed the heterogeneous-information-network-based graph embedding method to generate the candidate ranking lists of herbs that target structural, nonstructural and accessory SARS-CoV-2 proteins, individually. To obtain precision synthetic effective treatments forvarious COVID-19 infected stages, we employed the variational graph convolutional network method to generate candidate herb combinations as the recommended therapeutic therapies. Results There were 24 ranking lists, each containing top-10 herbs, targeting 24 SARS-CoV-2 proteins correspondingly, and 20 herb combinations were generated as the candidate-specific treatment to target the four infected stages. The code and supplementary materials are freely available at https://github.com/fanyang-AI/TCM-COVID19.

Publisher

Oxford University Press (OUP)

Subject

Molecular Biology,Information Systems

Reference85 articles.

1. Discovery of sars-cov-2 antiviral drugs through large-scale compound repurposing;Riva;Nature,2020

2. Comprehensive consensus analysis of SARS-CoV-2 drug repurposing campaigns;Journal of Chemical Information and Modeling 61,2021

3. The global phosphorylation landscape of sars-cov-2 infection;Bouhaddou;Cell,2020

4. Commentary:“a systems view on the future of medicine: inspiration from chinese medicine?”;Verpoorte;J Ethnopharmacol,2009

5. Chemical composition of selected commercial herbal remedies in relation to geographical origin and inter-species diversity;Konieczynski;Biol Trace Elem Res,2018

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3